Shi X - Search Results

1

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma.

Ji J, Zhao L, Budhu A, Forgues M, Jia HL, Qin LX, Ye QH, Yu J, Shi X, Tang ZY, Wang XW. Ji J, et al. Among authors: shi x. J Hepatol. 2010 May;52(5):690-7. doi: 10.1016/j.jhep.2009.12.025. Epub 2010 Mar 1. J Hepatol. 2010. PMID: 20338660 Free PMC article.

2

[Current treatment and progress of hepatocellular carcinoma with portal vein tumor thrombus].

Li L, Li Z, Lu H, Zhao L, Shi X. Li L, et al. Among authors: shi x. Zhonghua Wai Ke Za Zhi. 2015 Jun 1;53(6):468-71. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26359063 Chinese.

3

Should hepatic dysplastic nodules and regenerative nodules be regarded as premalignant lesions and treated?

Zhao L, Wong LL, Shi X, Ji J. Zhao L, et al. Among authors: shi x. Hepatology. 2016 Oct;64(4):1370. doi: 10.1002/hep.28444. Epub 2016 Mar 4. Hepatology. 2016. PMID: 26754160 No abstract available.

4

Synchronous giant hepatic adenoma in siblings-A case report and brief literature review.

Zhang C, Shi X, Zhao L. Zhang C, et al. Among authors: shi x. Cancer Biol Ther. 2016 Jul 2;17(7):727-31. doi: 10.1080/15384047.2016.1177682. Epub 2016 Apr 20. Cancer Biol Ther. 2016. PMID: 27096392 Free PMC article. Review.

5

A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature.

Zhang C, Zhang W, Mu D, Shi X, Zhao L. Zhang C, et al. Among authors: shi x. Onco Targets Ther. 2016 Sep 22;9:5797-5802. doi: 10.2147/OTT.S103291. eCollection 2016. Onco Targets Ther. 2016. PMID: 27703378 Free PMC article.

6

Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.

Zhou Y, Dong X, Xiu P, Wang X, Yang J, Li L, Li Z, Sun P, Shi X, Zhong J. Zhou Y, et al. Among authors: shi x. Oxid Med Cell Longev. 2020 Mar 24;2020:7079308. doi: 10.1155/2020/7079308. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32273947 Free PMC article.

7

Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma.

Zhang B, Yue J, Shi X, Cui K, Li L, Zhang C, Sun P, Zhong J, Li Z, Zhao L. Zhang B, et al. Among authors: shi x. BMJ Open. 2022 Sep 17;12(9):e060955. doi: 10.1136/bmjopen-2022-060955. BMJ Open. 2022. PMID: 36115673 Free PMC article.

8

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

Zhang B, Shi X, Cui K, Li Z, Li L, Liu Z, Zhang C, Sun P, Zhong J, Sun Z, Chang Z, Ma Z, Gordon-Weeks A, Li M, Zhao L. Zhang B, et al. Among authors: shi x. BMC Cancer. 2023 May 20;23(1):465. doi: 10.1186/s12885-023-10955-7. BMC Cancer. 2023. PMID: 37210519 Free PMC article.

9

Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.

Cui K, Li Z, Zhong J, Shi X, Zhao L, Li H, Ma Y. Cui K, et al. Among authors: shi x. Front Oncol. 2024 Feb 6;14:1355798. doi: 10.3389/fonc.2024.1355798. eCollection 2024. Front Oncol. 2024. PMID: 38380371 Free PMC article.

10

Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years.

Chang Z, Li M, Sun Z, Liu Z, Yang Y, Xu L, Li L, Zhang C, Sun P, Zhong J, Zhang B, Shi X, Cui K, Zhang J, Li Z, Zhao L. Chang Z, et al. Among authors: shi x. BMC Gastroenterol. 2024 Oct 17;24(1):369. doi: 10.1186/s12876-024-03457-8. BMC Gastroenterol. 2024. PMID: 39420264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,085 results

Search Page

Filters